2 Suppliers
1 Customers
1 Debt Items
20 Related Chains
Search ALMS in the supply chain database
Create ALMS supply chain alerts
Read ALMS supply chain intel
ORANGE supply chain
NVIDIA Corporation supply chain
Amazon.com, Inc. supply chain
Johnson & Johnson supply chain
Suppliers 2
Clients 1
Debt 1
Acquisitions 0
Ownership 1
Secondary 20
Alumis Inc. Suppliers
Ticker Name Confidence Evidence
ORANY
ORANY
72%
available for physicians to prescribe. After that, the MHLW lists its National Health Insurance price within 60 days (or 90 days at the latest) from the approval, and physicians can obtain reimbursem…
ORANY
ORANY
72%
Reciprocal relationship from ORANY graph: Reciprocal relationship from ALMS graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from ALMS graph: available for physicians to presc…
Alumis Inc. Customers
Ticker Name Confidence Evidence
KAKEN
KAKEN
92%
All of the Company's revenues are currently earned under its license and collaboration agreement with Kaken.
Alumis Inc. Debt Obligations
Instrument Description Confidence Evidence
ALMS-DEBT
Debt stack $35.7M
90%
Market cache reports total debt of $35.7M.
Alumis Inc. Acquisitions
No acquisitions on record No completed or pending acquisitions found in our database for Alumis Inc..
Alumis Inc. Ownership
Holder Name Confidence Evidence
ALMS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 199 tracked holders.
Alumis Inc. Extended Supply Chain Network
Ticker Name Chain Index Hops Relationship Types
ZBIO
Zenas BioPharma, Inc.
100.00
2
CABA
Cabaletta Bio, Inc.
100.00
2
KYTX
Kyverna Therapeutics, Inc.
100.00
2
JBIO
Jade Biosciences, Inc.
100.00
2
ORANY
ORANGE
100.00
1
['supplier']
VERA
Vera Therapeutics, Inc.
100.00
2
CGEM
Cullinan Therapeutics, Inc.
100.00
2
TKPHF
Takeda Pharmaceutical Company Limited
100.00
2
VRTX
Vertex Pharmaceuticals Incorporated
100.00
2
KAKEN
KAKEN
63.48
1
['receiving']
D
Dominion Energy, Inc.
50.00
2
CLNE
Clean Energy Fuels Corp.
50.00
2
FENC
Fennec Pharmaceuticals Inc.
50.00
2
EQR
Equity Residential
50.00
2
CHUC
Charlie's Holdings, Inc.
50.00
2
AYTU
Aytu BioPharma, Inc.
50.00
2
AMZE
Amaze Holdings, Inc.
50.00
2
DFTX
Definium Therapeutics, Inc.
50.00
2
SCNX
Scienture Holdings, Inc.
50.00
2
CANF
Can-Fite BioPharma Ltd.
50.00
2